Sec Form 13G Filing - Nussbaum Ran @ PURPLE BIOTECH LTD.

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Amendment No. 1)*

(Rule 13d-102)

Under the Securities Exchange Act of 1934

PURPLE BIOTECH LTD.

(Name of Issuer)

American Depositary Shares, each ADS
represents one (1) Ordinary Share, no par value
(Title of Class of Securities)

49803V107**

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

** 49803V107 is the CUSIP number for the American Depository Shares traded on the Nasdaq Stock Market. The ISIN number for the Ordinary Shares is IL0007650166.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 49803V107

13G

Page 2 of 12 Pages

Names of Reporting Persons

Pontifax (Israel) II L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(a) ☐

(b) ☐

SEC Use Only

Citizenship or Place of Organization

Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

80,753¹ ADSs

Sole Dispositive Power

Shared Dispositive Power

80,753¹ ADSs

Aggregate Amount Beneficially Owned by Each Reporting Person

80,753¹ ADSs

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

0.5%

12.

Type of Reporting Person (See Instructions)

Pontifax Management II L.P. ("Pontifax Management") is the general partner of the Pontifax (Israel) II - Individual Investors, L.P., Pontifax (Israel) II L.P., and Pontifax (Cayman) II L.P., and Pontifax Management 2 G.P. (2007) Ltd. ("Pontifax Management GP") is the general partner of Pontifax Management. Mr. Kariv and Ran Nussbaum are directors of Pontifax Management GP and, as such, hold voting and/or dispositive power over the ADSs held by these entities.

CUSIP No. 49803V107

13G

Page 3 of 12 Pages

Names of Reporting Persons

Pontifax (Cayman) II L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(a) ☐

(b) ☐

SEC Use Only

Citizenship or Place of Organization

Cayman Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

107,205¹ ADSs

Sole Dispositive Power

Shared Dispositive Power

107,205¹ ADSs

Aggregate Amount Beneficially Owned by Each Reporting Person

107,205¹ ADSs

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

0.6%

12.

Type of Reporting Person (See Instructions)

Pontifax Management is the general partner of the Pontifax (Israel) II - Individual Investors, L.P., Pontifax (Israel) II L.P., and Pontifax (Cayman) II L.P., and Pontifax Management GP is the general partner of Pontifax Management. Mr. Kariv and Ran Nussbaum are directors of Pontifax Management GP and, as such, hold voting and/or dispositive power over the ADSs held by these entities.

CUSIP No. 49803V107

13G

Page 4 of 12 Pages

Names of Reporting Persons

Ran Nussbaum

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(d) ☐

SEC Use Only

Citizenship or Place of Organization

Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

219,306 ADSs¹

Sole Dispositive Power

Shared Dispositive Power

219,306 ADSs¹

Aggregate Amount Beneficially Owned by Each Reporting Person

219,306 ADSs¹

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

1.3%

12.

Type of Reporting Person (See Instructions)

Consists of (a) 31,348 ADSs owned by Pontifax (Israel) II - Individual Investors, L.P.; (b) 80,753 ADSs owned by Pontifax (Israel) II L.P., and (c) 107,205 ADSs owned by Pontifax (Cayman) II L.P. Pontifax Management is the general partner of the Pontifax (Israel) II - Individual Investors, L.P., Pontifax (Israel) II L.P., and Pontifax (Cayman) II L.P., and Pontifax Management GP is the general partner of Pontifax Management. Mr. Kariv and Ran Nussbaum are directors of Pontifax Management GP and, as such, hold voting and/or dispositive power over the ADSs held by these entities.

CUSIP No. 49803V107

13G

Page 5 of 12 Pages

Names of Reporting Persons

Tomer Kariv

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(e) ☐

(f) ☐

SEC Use Only

Citizenship or Place of Organization

Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

219,306 ADSs¹

Sole Dispositive Power

Shared Dispositive Power

219,306 ADSs¹

Aggregate Amount Beneficially Owned by Each Reporting Person

219,306 ADSs¹

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

1.3%

12.

Type of Reporting Person (See Instructions)

CUSIP No. 49803V107

13G

Page 6 of 12 Pages

Names of Reporting Persons

Pontifax Management II L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(g) ☐

(h) ☐

SEC Use Only

Citizenship or Place of Organization

Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

219,306 ADSs¹

Sole Dispositive Power

Shared Dispositive Power

219,306 ADSs¹

Aggregate Amount Beneficially Owned by Each Reporting Person

219,306 ADSs¹

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

1.3%

12.

Type of Reporting Person (See Instructions)

CUSIP No. 49803V107

13G

Page 7 of 12 Pages

Names of Reporting Persons

Pontifax Management 2 G.P. (2007) Ltd.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(See Instructions)

(i) ☐

(j) ☐

SEC Use Only

Citizenship or Place of Organization

Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

Sole Voting Power

Shared Voting Power

219,306 ADSs¹

Sole Dispositive Power

Shared Dispositive Power

219,306 ADSs¹

Aggregate Amount Beneficially Owned by Each Reporting Person

219,306 ADSs¹

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

☐

11.

Percent of Class Represented by Amount in Row (9)

1.3%

12.

Type of Reporting Person (See Instructions)

CUSIP No. 49803V107

13G

Page 8 of 12 Pages

Introductory Note: This Schedule 13G is filed on behalf of Pontifax (Israel) II L.P., a limited partnership organized under the laws of the State of Israel and Pontifax (Cayman) II, L.P., a limited partnership organized under the laws of the Cayman Islands, Pontifax Management II L.P., a limited partnership organized under the laws of the State of Israel, Pontifax Management 2 G.P. (2007) Ltd., an Israeli company, Ran Nussbaum and Tomer Kariv, in respect of ADSs of Purple Biotech Ltd. (formerly known as Kitov Pharma Ltd.).

Item 1(a).

Name of Issuer:

PURPLE BIOTECH LTD.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

One Azrieli Center, Round Tower, 132 Menachem Begin Road, Tel Aviv 6701101, Israel

Item 2(a).

Name of Person Filing:

This Statement is filed on behalf of Pontifax (Israel) II L.P., Pontifax (Cayman) II L.P., Pontifax Management II L.P., Pontifax Management 2 G.P. (2007) Ltd., Ran Nussbaum and Tomer Kariv.

Item 2(b).

Address of Principal Offices or, if None, Residence:

The addresses of the Reporting Persons are:

Pontifax (Israel) II L.P. - 14 Shenkar St. Herzliya, 46140, Israel

Pontifax (Cayman) II, L.P. - PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands

Pontifax Management II L.P. - 14 Shenkar St. Herzliya, 46140, Israel

Pontifax Management 2 G.P. (2007) Ltd. – 14 Shenkar St. Herzliya, 46140, Israel

Ran Nussbaum - 14 Shenkar St. Herzliya, 46140, Israel

Tomer Kariv - 14 Shenkar St. Herzliya, 46140, Israel

Item 2(c).

Citizenship:

Pontifax (Israel) II L.P. is organized in the State of Israel, Pontifax (Cayman) II L.P. is organized in the Cayman Islands, Pontifax Management II L.P. is organized in the State of Israel, Pontifax Management 2 G.P. (2007) Ltd. is incorporated in the State of Israel, Ran Nussbaum is a citizen of the State of Israel, and Tomer Kariv is a citizen of the State of Israel.

Item 2(d).

Title of Class of Securities: ADSs

Item 2(e).

CUSIP Number: 49803V107

CUSIP No. 49803V107

13G

Page 9 of 12 Pages

Item 3.

If the Statement is being filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the filing person is a: Not applicable.

(a)

☐

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

☐

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

☐

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

☐

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

☐

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

☐

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

☐

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

☐

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

☐

A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

(j)

☐

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

(k)

☐

Group, in accordance with §240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Item 4.

Ownership.

(a)

Amount beneficia lly owned:

219,306 ADSs¹

(b)

Percent of class:

1.3%¹

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or direct the vote: 0

(ii)

Shared power to vote or direct the vote: 219,306 ADSs¹

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 219,306 ADSs¹

CUSIP No. 49803V107

13G

Page 10 of 12 Pages

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person had ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

Item 9.

Notice of Dissolution of Group.

Not applicable.

Item 10.

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 49803V107

13G

Page 11 of 12 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 2, 2021

PONTIFAX (ISRAEL) II L.P.

By:	/s/ Pontifax Management II L.P.
Name:	Pontifax Management II L.P.
Title:	General Partner

By:	/s/ Pontifax Management 2 G.P. (2007) LTD.
Name:	Pontifax Management 2 G.P. (2007) LTD.
Title:	General Partner

By:	/s/ Ran Nussbaum
Name:	Ran Nussbaum
Title:	Director

PONTIFAX (CAYMAN) II L.P.

By:	/s/ Pontifax Management II L.P.
Name:	Pontifax Management II L.P.
Title:	General Partner

By:	/s/ Pontifax Management 2 G.P. (2007) LTD.
Name:	Pontifax Management 2 G.P. (2007) LTD.
Title:	General Partner

By:	/s/ Ran Nussbaum
Name:	Ran Nussbaum
Title:	Director

PONTIFAX MANAGEMENT II L.P.

By:	/s/ Pontifax Management 2 G.P. (2007) LTD.
Name:	Pontifax Management 2 G.P. (2007) LTD.
Title:	General Partner

By:	/s/ Ran Nussbaum
Name:	Ran Nussbaum
Title:	Director

PONTIFAX MANAGEMENT 2 G.P. (2007) LTD.

By:	/s/ Ran Nussbaum
Name:	Ran Nussbaum
Title:	Director

/s/ Ran Nussbaum
RAN NUSSBAUM

/s/ Tomer Kariv
TOMER KARIV

Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

CUSIP No. 49803V107

13G

Page 12 of 12 Pages

EXHIBIT INDEX

Joint Filing Agreement, dated as of February 2, 2021, by and among Pontifax (Israel) II L.P., Pontifax (Cayman) II L.P., Pontifax Management II L.P., Pontifax Management 2 G.P. (2007) Ltd., Ran Nussbaum and Tomer Kariv. (Incorporated by reference from the Schedule 13G filed by the Reporting Persons with respect to the Issuer on February 13, 2020).

Sec Form 13G Filing - Nussbaum Ran filing for PURPLE BIOTECH LTD. (PPBT) - 2021-02-05